Ophthalmic and Topical Dosage Form New Animal Drugs; Ivermectin Suspension
other · Food and Drug Administration · Rule · Published 2001-01-24 · Effective 2001-01-24 · 66 FR 7577
Document
Document number
01-1869
Federal Register citation
66 FR 7577
CFR reference
21 CFR 510
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2001-01-24
Effective date
2001-01-24
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Blue Ridge Pharmaceuticals, Inc. The NADA provides for veterinary prescription use of ivermectin otic suspension for the treatment of adult ear mite infestations in cats and kittens.